LifeStance Health (LFST) FCF Margin (2020 - 2026)

LifeStance Health has disclosed FCF Margin across 7 years of filings, most recently posting 5.54% for Q1 2026.

• In Q1 2026, FCF Margin rose 862.0% year-over-year to 5.54%; the TTM figure through Mar 2026 stood at 9.54% (up 157.0% YoY), while the FY2025 annual figure was 7.72%, up 87.0% from the prior year.
• FCF Margin retreated to 5.54% in Q1 2026, from 12.21% in the prior quarter.
• Over the last five years, FCF Margin for LFST reached as high as 17.21% in Q4 2024 and fell as low as 13.37% in Q3 2023.
• The 5-year median for FCF Margin is 1.92% (2023), against an average of 1.53%.
• Annual changes were most pronounced in 2022 — FCF Margin slumped 1129 bps — and 2024, when it jumped 1902 bps.
• A 5-year view of FCF Margin shows it stood at 11.13% in 2022, then sank by 83 bps to 1.92% in 2023, then jumped by 797 bps to 17.21% in 2024, then retreated by 29 bps to 12.21% in 2025, then tumbled by 55 bps to 5.54% in 2026.
• According to Business Quant data, FCF Margin over the past three periods registered 5.54%, 12.21%, and 4.67% for Q1 2026, Q4 2025, and Q3 2025 respectively.